Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment

Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis

(2014) Konstantinos Toulis et al.   Hormones-International Journal of Endocrinology and Metabolism

Vitamin D deficiency in white, apparently healthy, free-living adults in a temperate region

(2014) Panagiotis Singhellakis et al.   Hormones-International Journal of Endocrinology and Metabolism

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy

(2012) E. Terpos et al.   ANNALS OF ONCOLOGY

TGF-β regulates sclerostin expression via the ECR5 enhancer

(2011) Gabriela G. Loots et al.   BONE

The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair

(2011) David M. de Kretser et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys

(2010) Sutada Lotinun et al.   BONE

Activin A and bone metastasis

(2010) Gaetano Leto   JOURNAL OF CELLULAR PHYSIOLOGY

Effects of Suppression of Follicle-Stimulating Hormone Secretion on Bone Resorption Markers in Postmenopausal Women

(2010) Matthew T. Drake et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease

(2010) S. Vallet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin

(2009) Kristy M. Nicks et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study of ACE-011 (ActRIIA-IgG1) in Postmenopausal Women*

(2008) Jon Ruckle et al.   JOURNAL OF BONE AND MINERAL RESEARCH